- Home
- IGMS vs FDSB Comparison
IGMS vs FDSB Comparison
Compare IGMS & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- FDSB
- Stock Information
- Founded
- IGMS 1993
- FDSB 1926
- Country
- IGMS United States
- FDSB United States
- Employees
- IGMS N/A
- FDSB N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- FDSB
- Sector
- IGMS Health Care
- FDSB
- Exchange
- IGMS Nasdaq
- FDSB NYSE
- Market Cap
- IGMS 81.9M
- FDSB 69.2M
- IPO Year
- IGMS 2019
- FDSB N/A
- Fundamental
- Price
- IGMS $1.27
- FDSB $13.18
- Analyst Decision
- IGMS Hold
- FDSB
- Analyst Count
- IGMS 8
- FDSB 0
- Target Price
- IGMS $6.00
- FDSB N/A
- AVG Volume (30 Days)
- IGMS 1.3M
- FDSB 23.0K
- Earning Date
- IGMS 08-13-2025
- FDSB 08-15-2025
- Dividend Yield
- IGMS N/A
- FDSB N/A
- EPS Growth
- IGMS N/A
- FDSB N/A
- EPS
- IGMS N/A
- FDSB 0.02
- Revenue
- IGMS $2,681,000.00
- FDSB $12,612,000.00
- Revenue This Year
- IGMS $252.44
- FDSB N/A
- Revenue Next Year
- IGMS $46.48
- FDSB N/A
- P/E Ratio
- IGMS N/A
- FDSB $555.11
- Revenue Growth
- IGMS 27.36
- FDSB 40.41
- 52 Week Low
- IGMS $0.92
- FDSB $9.85
- 52 Week High
- IGMS $22.50
- FDSB $14.50
- Technical
- Relative Strength Index (RSI)
- IGMS 48.73
- FDSB N/A
- Support Level
- IGMS $1.26
- FDSB N/A
- Resistance Level
- IGMS $1.37
- FDSB N/A
- Average True Range (ATR)
- IGMS 0.03
- FDSB 0.00
- MACD
- IGMS -0.01
- FDSB 0.00
- Stochastic Oscillator
- IGMS 8.33
- FDSB 0.00
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay.